We helped a top-10 diagnostics company to define the value proposition for clinical algorithms, map reimbursement pathways, and identify relevant CPT codes.

What was the digital health solution?

A collection of algorithm-based clinical decision support products used to identify patients groups at a high risk of acute and chronic conditions.

What was the objective?

To quickly understand what commercialisation pathways existed for clinical algorithms in the US.

 

How did we do it?

  • Engaged a market access and reimbursement specialist in the US to map reimbursement pathways and identify relevant CPT codes/fee schedules.
  • Compiled five detailed case studies of similar technologies that have been successfully commercialised.
  • Interviewed 14 experts, including purchasing decision-makers at provider organisations, and public and private payers.
Previous
Previous

We helped a life sciences company to optimise reimbursement of remote care services in the US using their remote monitoring solution.

Next
Next

We used clinical simulation to trial a clinical decision support tool with US oncologists in just 5 months